Humana Says Continue To Anticipate FY 2025 Net Patient Growth Of 30,000 To 50,000 Reflecting About 10% Growth At Midpoint
View all comments(0)
April 30 (Reuters) - Humana Inc HUM.N:
HUMANA -"ADVANCING CENTERWELL & MEDICAID STRATEGIES WHICH ARE EXPECTED TO DRIVE INCREASED EARNINGS CONTRIBUTION OVER MID AND LONGER TERM"
HUMANA: CONTINUE TO ANTICIPATE FY 2025 NET PATIENT GROWTH OF 30,000 TO 50,000, REFLECTING ABOUT10% GROWTH AT MIDPOINT - PREPARED REMARKS
HUMANA: OUTLOOK FY INDIVIDUAL MEDICARE ADVANTAGE TO DECLINE ABOUT 550,000 MEMBERS
HUMANA: RATE UPDATES FOR ABOUT 75% OF MEDICAID REVENUE ARE PROJECTED AS FINAL FOR 2025
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Why SanDisk Stock Could Soar to $4,000?

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

AI Chip Sector Adds Heavyweight Player, Nvidia Rival Cerebras Plans to List Next Week, Targeting Largest US IPO of the Year

Global First Storage ETF Surges 88% Five Weeks After Listing. Is It Too Late to Buy Now?

Trump Administration Brokers. Intel and Apple Reach Chipmaking Agreement, Shares Surge More Than 13%

Tradingkey








Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.